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ABSTRACT
Background Increased bronchial responsiveness is
characteristic of asthma. Gas cooking, which is a major
indoor source of the highly oxidant nitrogen dioxide, has
been associated with respiratory symptoms and reduced
lung function. However, little is known about the effect
of gas cooking on bronchial responsiveness and on how
this relationship may be modiﬁed by variants in the
genes GSTM1, GSTT1 and GSTP1, which inﬂuence
antioxidant defences.
Methods The study was performed in subjects with
forced expiratory volume in one second at least 70% of
predicted who took part in the multicentre European
Community Respiratory Health Survey, had bronchial
responsiveness assessed by methacholine challenge and
had been genotyped for GSTM1, GSTT1 and GSTP1-
rs1695. Information on the use of gas for cooking was
obtained from interviewer-led questionnaires. Effect
modiﬁcation by genotype on the association between
the use of gas for cooking and bronchial responsiveness
was assessed within each participating country, and
estimates combined using meta-analysis.
Results Overall, gas cooking, as compared with
cooking with electricity, was not associated with
bronchial responsiveness (β=−0.08, 95% CI −0.40 to
0.25, p=0.648). However, GSTM1 signiﬁcantly modiﬁed
this effect (β for interaction=−0.75, 95% CI −1.16 to
−0.33, p=4×10−4), with GSTM1 null subjects showing
more responsiveness if they cooked with gas. No effect
modiﬁcation by GSTT1 or GSTP1-rs1695 genotypes was
observed.
Conclusions Increased bronchial responsiveness was
associated with gas cooking among subjects with the
GSTM1 null genotype. This may reﬂect the oxidant
effects on the bronchi of exposure to nitrogen dioxide.
INTRODUCTION
Gas cooking is a major source of indoor nitrogen
dioxide and, to a lesser extent, of ﬁne particles.1 2
Use of gas for cooking has been inconsistently asso-
ciated with respiratory symptoms, including wheeze
and exacerbation of asthma, and reduced lung func-
tion suggestive of airways obstruction,3–6 and only a
few studies have examined associations with bron-
chial responsiveness (BR). In a study of 324 Montreal
school children, those exposed to gas cooking were
more likely to have increased BR.7 In the Dutch arm
of the European Community Respiratory Health
Survey (ECRHS), which involved 1921 adults, gas
cooking was also associated with increased BR, but
only among those with high total immunoglobulin E
(IgE) levels.8 In contrast, in a study of 929 eight-year-
old Dutch children, exposure to gas cooking was not
associated with BR.9
Nitrogen dioxide is an oxidant species that induces
upregulation of the expression of T helper type 2 cell
cytokines and ICAM1 as well as neutrophilic inﬂam-
mation in bronchial epithelium.10 11 Changes in air
particle number concentrations have also been linked
to airway inﬂammation.12 The extent to which these
and other pollutants cause lung damage and inﬂam-
mation is dependent on the efﬁcacy of internal anti-
oxidant defences and detoxiﬁcation mechanisms.
Glutathione-S-transferases are a group of phase II
enzymes involved in the detoxiﬁcation of xenobiotics
in the lung.13 These enzymes play a role in the pro-
tection against oxidative stress since they inﬂuence
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Key messages
What is the key question?
▸ Is the relationship of bronchial responsiveness
with use of gas for cooking modiﬁed by
variants in oxidative stress-related genes
(GSTM1, GSTT1, GSTP1)?
What is the bottom line?
▸ In subjects with GSTM1 null genotype,
increased bronchial responsiveness was
associated with gas cooking, which may reﬂect
the oxidant effects on the bronchi of exposure
to gas-derived pollutants.
Why read on?
▸ Since increased bronchial responsiveness is a
characteristic feature of asthma, the present
ﬁndings may help in understanding why some
individuals may present asthma-related
symptoms when cooking with gas while others
do not.
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the levels of glutathione, an important non-enzymatic antioxidant
in the lung.14 15 Variants in genes encoding
glutathione-S-transferase mu 1 (GSTM1), theta 1 (GSTT1) and pi
1 (GSTP1) have been linked to decreased lung function and pro-
gression from increased BR to asthma,16–18 suggesting that these
variants contribute to increased susceptibility to oxidative stress.
Thus, the aim of study was to assess whether genetic variants in
GSTM1 (null genotype), GSTT1 (null genotype) and GSTP1
(rs1695[G]) modify the association between gas cooking and BR.
METHODS
Participants
Data included in the following analysis were collected from sub-
jects participating in the ECRHS, an international multicentre
cohort study designed to identify risk factors for asthma.19 In
the ﬁrst survey (ECRHS I), subjects were randomly recruited
from community-based sampling frames in each centre after
completing a short postal screening questionnaire. A random
sample of responders to the postal survey completed an
interviewer-led questionnaire between 1992 and 1994
(‘random’ group). A smaller sample of participants with symp-
toms highly suggestive of asthma, but who had not been ran-
domly selected to take part, was also invited for clinical
assessment (‘enriched’ group). Approximately 8 years later, sub-
jects who had participated in the clinical investigations during
the ﬁrst survey were invited for further questionnaires and
blood sampling for genotyping (ECRHS II: 1999–2002). The
main analysis herein presented is based on data collected in
ECRHS II.
Ethical approval for the study from local research ethics com-
mittees and written consent from subjects were obtained.
Genotyping
In total, 19 of 29 centres (8109 out of 10 933 subjects) in ECRHS
II collected blood samples for genotyping (ﬁgure 1). However, not
all subjects provided blood samples, and some of the collected
samples had inadequate amount of or poor quality DNA. Only
5065 out of the 8109 subjects were genotyped for GSTM1,
GSTP1 and GSTT1. Genotyped subjects were slightly older than
those who were not genotyped, and as there were some between-
country differences in response to genotyping, the distribution by
country was not the same between the two groups (see online sup-
plementary T1). DNA was extracted from blood samples using a
commercial kit (Puregene, Gentra Inc., MN, USA). At the Centre
for Genomic Regulation (Barcelona, Spain), GSTM1 and GSTT1
null genotypes were determined by PCRs, and GSTP1 polymorph-
ism (rs1695—Ile105Val) was genotyped using a speciﬁc pyrose-
quencing assay.20 Genotype frequencies at GSTP1-rs1695 deviated
from Hardy–Weinberg equilibrium (HWE) in France and
Germany. HWE could not be calculated for GSTM1 and GSTT1
because our data did not distinguish between one and two copies
of the variant allele. Population stratiﬁcation was assessed with 26
unlinked markers using the genomic control approach and the
EIGENSTRAT software. There was no evidence of relevant popu-
lation stratiﬁcation.20
Exposure to gas cooking
Participants were asked, “What kind of stove do you mostly use
for cooking?” Subjects who answered ‘gas (gas from the mains)’
or ‘gas (gas from bottles or other non-mains source)’ were clas-
siﬁed as being exposed to gas cooking. Those who answered
‘electric’ or ‘microwave’ were classiﬁed as the reference group.
Subjects in four centres in Norway (N=436) and Sweden
(N=643) were not included in the analysis because the use of
gas for cooking in these countries is extremely low (<1%).
Subjects who used other types of stove, such as ‘coal, coke or
wood (solid fuel)’ or ‘parafﬁn (kerosene)’, were also excluded
(<2% of participants in the analysis, N=71).
Bronchial responsiveness
BR was assessed by methacholine bronchial challenge test as
previously described.21 To assess the baseline forced expiratory
volume in one second (FEV1) and the forced vital capacity
(FVC), each participant was allowed nine attempts to provide at
least two technically acceptable expiratory manoeuvres. Subjects
with FEV1 at least 70% of predicted, and more than 1.5 L,
underwent bronchial challenge unless they had speciﬁc contrain-
dications. Bronchial challenge was conducted with increasing
amounts of methacholine up to a cumulative dose of 1 mg, with
the methacholine solution being administered via a dosimeter.
BR was deﬁned by the slope of the dose–response curve
obtained with the methacholine test. The ‘slope’ was estimated
as rate of change of FEV1 against methacholine dose and, in
order to satisfy the assumption of normality and homogeneity
of variance, transformed to 100/(log-slope+10).21 22 A low
slope is indicative of high BR. In addition, subjects who experi-
enced more than a 20% fall in FEV1 after inhalation of 1 mg of
methacholine were identiﬁed, that is, those with PD20 <1 mg.
In ECRHS II, two centres in Belgium (N=503) did not perform
the methacholine challenge test and their data were excluded.
Statistical analysis
Main analysis: ECRHS II
To assess whether genetic variants in GSTM1, GSTT1 and
GSTP1 modify the association between gas cooking and BR,
linear regression models with the slope as the continuous
dependent variable were ﬁtted for each of the three genes and a
gene–gas cooking interaction term was entered in the models.
GSTM1 and GSTT1 were modelled as dichotomous variables
(‘null’ vs ‘present’), whereas GSTP1-rs1695[G] was modelled
per number of minor alleles (0, 1, 2) under an additive mode of
inheritance. The coefﬁcient (β) for the interaction term between
each of the genes and gas cooking was estimated for the whole
sample (‘random’ and ‘enriched’) in each country and then com-
bined using a random effects meta-analysis.23 This was repeated
adding in the model a term for the type of sample. The analysis
was also repeated for both sexes, separately.
Potential confounders considered a priori to be relevant
included the following: age, sex, height, smoking in pack-years,
speciﬁc IgE titre (cat, house dust mite, Timothy-grass,
Cladosporium herbarum), total IgE, baseline FEV1 expressed as
a standardised difference from an internally derived sex-speciﬁc
predicted value and baseline FEV1 as a percentage of FVC. An
age–sex interaction24 and a gene–smoking interaction, as sug-
gested in the literature,21 were also considered. In addition, the
interaction between each genetic variant and BR was further
adjusted for the other genetic variants. After excluding subjects
with missing slope, genotype and any of the potential confoun-
ders included in the models, the total sample consisted of 2208
for models assessing the interaction between gas cooking and
GSTM1 or GSTT1, and 2444 for models assessing the inter-
action with GSTP1 (ﬁgure 1). Statistical tests were two-sided,
and results were considered signiﬁcant when nominal p≤0.05.
Statistical analyses were performed using STATA/IC V.12.1.25
Sensitivity and post hoc analyses
Details on the sensitivity and post hoc analyses are provided in
the online supplementary material.
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RESULTS
Main results: ECRHS II
In the present study, both sexes were equally represented, most
subjects were ever smokers (42.9% were lifetime non-smokers),
most were from Spain, France and Germany, and cooking with
gas was more prevalent than cooking with electricity (table 1).
GSTM1 and GSTT1 were not present in just above 50% and
approximately 20% of the subjects, respectively. Close to half of
the subjects were heterozygous for GSTP1-rs1695.
None of the three genetic variants was signiﬁcantly associated
with BR (see online supplementary T2). Overall, gas cooking,
versus cooking with electricity, was also not signiﬁcantly asso-
ciated with BR (β=−0.08, 95% CI −0.40 to 0.25, p=0.648).
However, this association was different depending on GSTM1,
with GSTM1 null subjects showing a strong signiﬁcant associ-
ation of increased BR with use of gas for cooking (β for
interaction=−0.75, 95% CI −1.16 to −0.33, p=4×10−4,
Bonferroni-corrected p=0.017) (table 2 and ﬁgure 2). There
was no evidence of heterogeneity between countries (I2=0%,
p=0.521). The interaction was present among males (β for
interaction=−0.79, 95% CI −1.63 to 0.06, p=0.067) and
females (β for interaction=−0.79, 95% CI −1.40 to −0.19,
p=0.010). Adjustment of these models for the type of sample, a
priori confounders and for the other genes did not materially alter
the estimates for the interaction (see online supplementary T3).
The association of BR with use of gas for cooking was not
Figure 1 Flow diagram showing the selection of subjects included in the analysis.
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modiﬁed by GSTT1 or GSTP1-rs1695 genotypes (table 2; see
online supplementary T4).
Sensitivity analysis
The interaction between gas cooking and GSTM1 was present
and of the same magnitude in the ‘random’ sample and the
smaller sample that was enriched in symptomatic subjects
(table 2). The estimate for the interaction was similar in those
who had gas hobs (without gas ovens), who used gas mains,
who cooked every day in the last 4 weeks, even in a ventilated
kitchen, and stronger in those who had gas hobs with gas ovens,
who used bottled gas and who cooked every day in the last
4 weeks in an unventilated kitchen (table 3). When the analysis
was restricted to lifetime non-smokers only (N=936), the mag-
nitude of interaction reduced slightly, although the direction
remained the same (β for interaction=−0.42, 95% CI −1.07 to
0.24, p=0.214).
When BR was considered as PD20, the prevalence of
increased BR in some centres was very low. Using this outcome,
no statistically signiﬁcant interaction was observed (OR for
interaction=1.29, 95% CI 0.64 to 2.62, p=0.478).
Post hoc analysis
Some analyses were repeated using all available data obtained at
ECRHS I (ie, including participants from Belgium). The inter-
action between gas cooking and GSTM1 was not present (β for
interaction=−0.001, 95% CI −0.45 to 0.44, p=0.996), and
there was some evidence of minor heterogeneity between coun-
tries in this relationship (I2=10.6%, p=0.349). As this post hoc
analysis included participants from Belgium (who did not
conduct BR measures at the follow-up), the analysis was
repeated excluding participants from that country but still no
interaction was observed (β for interaction=0.12, 95% CI
−0.35 to 0.58, p=0.628). Exclusion of Spain (country contrib-
uting the most to heterogeneity of results at ECRHS I) did not
alter results (β for interaction=−0.19, 95% CI −0.67 to 0.30,
p=0.452). Of note, Spain showed the largest change in the use
of gas cooking between the two surveys (84.2% to 54.8%,
online supplementary T5). Some subjects changed cooking fuel
between surveys (gas to electricity: N=483, of whom 35% were
from Spain; electricity to gas: N=139). Restriction of the ana-
lysis to those who used the same fuel at baseline and follow-up
still did not show an interaction between gas cooking and
GSTM1 in the ECRHS I. As in the second survey, interactions
between gas cooking and GSTT1 and GSTP1-rs1695 were not
observed in the baseline survey (p>0.05; data not shown).
Overall, there was no evidence that use of gas over the
approximately 8 years of follow-up was associated with greater
increases in BR (difference in change in slope comparing gas
Table 1 Characteristics of subjects from the two surveys of the
European Community Respiratory Health Survey (ECRHS) included in
the present analysis
ECRHS I
(N=2621)*
ECRHS II
(N=2546)*
Age, mean (SD) 34.2 (7.2) 42.2 (7.2)
Sex (%)
Males 50.4 49.4
Females 49.6 50.6
Smoking status (%)
Never smoker 42.9% 42.9%
Ever smoker 57.1% 57.1%
Smoking pack-years, mean (SD) 7.8 (12.5) 11.0 (17.6)
Country (%)
Australia 10.7 11.5
Belgium 11.8 –
Estonia – 5.1
France 15.5 17.1
Germany 13.1 13.0
Spain 30.4 35.5
Switzerland 8.8 9.4
UK 9.7 8.4
Cooking fuel (%)
Electricity 33.5 49.4
Gas 66.5 50.6
GSTM1 genotype (%)†
Null 51.1 51.2
Present 48.9 48.8
GSTT1 genotype (%)†
Null 19.8 20.2
Present 80.2 79.8
GSTP1-rs1695 genotype (%)‡
AA 42.8 41.7
AG 48.3 49.0
GG 8.9 9.3
Bronchial responsiveness, log-slope, mean (SD) 7.6 (2.3) 7.4 (2.3)
Fall of 20% in FEV1 after inhalation of 1 mg methacholine, PD20 (%)
No 84.2 83.1
Yes 15.8 16.9
Baseline FEV1, mean (SD) 3.7 (0.8) 3.6 (0.8)
Baseline FVC, mean (SD) 4.6 (1.0) 4.4 (1.0)
*After exclusion of subjects with missing data on cooking fuel or not using gas or
electric stove, who did not perform the methacholine challenge test or had missing
data on BR slope, and those with missing data on at least one of the terms in the
statistical model.
†314 subjects from ECRHS I and 338 subjects from ECRHS II have missing data on
GSTM1 and GSTT1 genotypes.
‡151 subjects from ECRHS I and 102 subjects from ECRHS II have missing data on
GSTP1-rs1695 genotype.
Table 2 Estimates for the interaction between gas cooking and genetic variants in GSTM1, GSTT1 and GSTP1 on bronchial responsiveness in
the European Community Respiratory Health Survey II
Genetic variant Whole sample ‘Random’ sample ‘Enriched’ sample*
N β (95% CI) p Value N β (95% CI) p Value N β (95% CI) p Value
GSTM1 null 2208 −0.75 (−1.16 to −0.33) 4×10−4 1843 −0.81 (−1.34 to −0.28) 0.003 365 −0.93 (−2.01 to 0.14) 0.088
GSTT1 null 2208 −0.02 (−0.54 to 0.50) 0.929 1843 −0.27 (−0.83 to 0.28) 0.336 365 0.74 (−0.57 to 2.04) 0.270
GSTP1-rs1695 2444 0.03 (−0.41 to 0.46) 0.905 2018 0.01 (−0.45 to 0.48) 0.954 426 0.31 (−0.48 to 1.11) 0.441
*France and Switzerland were considered as one group due to small numbers in those two countries.
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with electricity: −0.002, 95% CI −0.51 to 0.51, p=0.995,
N=1150). However, participants with the GSTM1 null geno-
type and who cooked with gas, compared with those who
cooked with electricity, throughout the period of follow-up
showed some sign of greater increase in BR (β for the inter-
action between gas cooking and GSTM1 on change in BR=
−0.25, 95% CI −0.88 to 0.38, p=0.437, N=1150). There was
no evidence that GSTT1 or GSTP1-rs1695 genotypes modiﬁed
the change in BR due to the use of gas (p>0.05; data not
shown).
DISCUSSION
In this population-based study of adults of European ancestry
and FEV1 at least 70% of predicted, the association of BR with
gas cooking was different depending on GSTM1, that is, gas
cooking was associated with increased BR among subjects with
the null genotype for GSTM1, but not among carriers of that
gene. Furthermore, the interaction was stronger among those
who cooked in conditions where higher exposure levels are
expected (ie, with gas oven and in unventilated kitchens). To
our knowledge, this is the ﬁrst study to assess and report this
interaction.
One of the strengths of the present study is its large popula-
tion sample derived from several areas of Europe. There was
some loss to follow-up between the two surveys but little reason
to believe that this would result in the detection of false gene–
environment interactions as loss to follow-up in subjects with
respiratory symptoms and cooking with gas, or electricity, are
unlikely to be related to genetic characteristics. The general
decrease in prevalence of cooking with gas across countries,
from the ﬁrst to the second survey, probably reﬂects a change in
house building trends and is also unlikely due to genetic
makeup. A strength of the study was the use of a standardised
protocol across participating centres to perform methacholine
bronchial challenge tests.22 The continuous non-censored slope
obtained from the bronchial challenge tests performs better
than PD20 in indicating BR.26
Despite the fact we were underpowered to detect interactions
between gas cooking and GSTT1 and GSTP1, we had enough
power (>90%) to detect an interaction with GSTM1 in both
surveys. However, we only observed it in ECRHS II. This may be
due to heterogeneity between countries being lower in ECRHS II
or to lack of information on some environmental exposure that
might have confounded the effect of gas cooking in the ﬁrst
survey. It may also be due to better insulated houses and conse-
quently increased concentration of indoor gases in the second
survey, but we do not have data to conﬁrm or reject this argu-
ment. We could not detect within-survey differences between age
groups, although there was some evidence of increasing BR due
to gas cooking among older participants with GSTM1 null
Figure 2 Interaction between gas
cooking and GSTM1 on bronchial
responsiveness, and association
between gas cooking and bronchial
responsiveness according to GSTM1
genotype, in the European Community
Respiratory Health Survey II.
Table 3 Estimates for the interaction between gas cooking and GSTM1 null genotype on bronchial responsiveness in the European Community
Respiratory Health Survey II, restricting the analysis according to cooking characteristics
Cooking characteristics N β (95% CI) p Value
Gas hobs (without gas oven) vs electricity 1565 −0.53 (−1.06 to −0.001) 0.050
Gas hobs (with gas oven) vs electricity 1393 −0.85 (−1.43 to −0.27) 0.004
Bottled gas vs electricity 814 −1.59 (−2.98 to −0.20) 0.025
Gas mains vs electricity 1934 −0.60 (−1.04 to −0.15) 0.009
Cooked every day in the last four weeks 1578 −0.72 (−1.32 to −0.12) 0.018
Cooked every day in the last four weeks (ventilated kitchen) 1205 −0.50 (−1.04 to 0.04) 0.071
Cooked every day in the last four weeks (unventilated kitchen) 373 −1.47 (−2.54 to −0.40) 0.007
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genotype, when comparing the second with the ﬁrst survey (data
not shown). While the change in cooking fuel between the two
surveys may, in part, explain that the interaction was statistically
signiﬁcant only in the most recent survey, we should not exclude
the potential role of other genes, epigenetic mechanisms and cel-
lular phenomena during normal ageing. Adjustment for GSTT1
and GSTP1-rs1695 did not make a difference on the estimates
for the interaction between GSTM1 and gas cooking, nor did
adjusting for NQO1-rs1800566, which has been proposed to
interact with GSTM1 and air pollutants on lung function (data
not shown).27 Detrimental effects of gene dosage changes (eg,
deletion, duplication) may eventually be avoided through com-
pensation at the transcriptional, post-transcriptional and protein
levels.28 29 However, the efﬁciency of this phenomenon may
decrease with ageing, and manifestation of the gene dosage
changes may arise late in life. This is supported by evidence from
studies on autosomal recessive diseases and mitochondrial disor-
ders showing that even among subjects with inherited causal
mutations a proportion may live several years or decades without
manifesting the disease.30 31 It is also possible that BR is affected
by ageing-related decline in baseline lung function; however, we
did not observe a relevant change in the estimate for the inter-
action after adjusting for FEV1 and FEV1/FVC ratio.
There is evidence of the inﬂuence of interactions between
GSTM1 and some environmental pollutants on asthma and
airway obstruction. In a study of school children, prevalence of
asthma was associated with maternal smoking during pregnancy,
but only among children with GSTM1 deletion.24 In a study of
adolescents and young adults with asthma, it was reported that
exposure to environmental tobacco smoke signiﬁcantly reduces
peak expiratory ﬂow rate among subjects with no copy of
GSTM1, but not among carriers of at least a copy of that
gene.32 In a randomised controlled trial with asthmatic children
and irrespective of the treatment being studied, forced expira-
tory ﬂow was signiﬁcantly reduced due to exposure to ozone
among children with no copy of GSTM1, but not among those
with at least a copy of GSTM1.33
GSTM1 is located on chromosome 1 where it encodes a
phase II enzyme involved in the detoxiﬁcation of electrophilic
xenobiotics, by conjugation with glutathione, and the protection
against oxidative and nitrosative stress.13–15 Knockdown of
GSTM1 in normal human bronchial epithelial cells has shown
that this gene may regulate diesel exhaust particle-induced
expression of IL-8 and IL-1β by modulation of reactive oxygen
species.34 In vitro and in vivo data have shown that knockout
mice for gstm1 have low ability to conjugate 1,2-dichloro-4-
nitrobenzene with glutathione.35 Thus, it is biologically plaus-
ible that the lack of GSTM1, common in approximately half of
the population of European ancestry, may lead to an increased
susceptibility to the effects of gas cooking, which is the main
source of indoor nitrogen dioxide and particulate matter.1 2
In summary, increased BR was associated with gas for cooking
among subjects with the null genotype for GSTM1. This may be
an indication of the oxidant effects on the bronchi of exposure
to nitrogen dioxide originating from cooking with gas. Further
larger studies are recommended to conﬁrm this ﬁnding and
better understand its mechanism of action.
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